Intelligence Platform

Patents

Browse 2,465 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 6808702

Treatment of disorders by implanting stem cells and/or progeny thereof into gastrointestin

The Board of Regents of the University of Texas System · Granted Tue Oct 26 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6809077

Cyclosporin analogs for the treatment of autoimmune diseases

Enanta Pharmaceuticals, Inc. · Granted Tue Oct 26 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6806354

Methods and compositions for inducing autoimmunity in the treatment of cancers

The Board of Regents of the University of Texas System · Granted Tue Oct 19 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6803386

Prostacyclin derivative containing compositions and methods of using the same for the trea

United Therapeutics Corporation · Granted Tue Oct 12 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6790980

Tannate compositions and methods of treatment

First Horizon Pharmaceutical Corporation · Granted Tue Sep 14 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6783760

Combined cancer treatment methods using therapeutic conjugates that bind to aminophospholi

The Board of Regents of the University of Texas System · Granted Tue Aug 31 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6784156

Cyclosporins for the treatment of respiratory diseases

Enanta Pharmaceuticals, Inc. · Granted Tue Aug 31 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6780995

Activated iododerivatives for the treatment of cancer and aids

Isotechnika, Inc. · Granted Tue Aug 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6780413

Immunotoxin (mAB-RICIN) for the treatment of focal movement disorders

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6770624

Treatment of heart failure with growth hormone

The Regents of the University of California · Granted Tue Aug 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6764681

Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jul 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6759044

Cryptopain antibodies for prophylaxis, treatment, diagnosis and detection of Cryptosporidi

The Regents of the University of California · Granted Tue Jul 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6749853

Combined methods and compositions for coagulation and tumor treatment

The Board of Regents of the University of Texas System · Granted Tue Jun 15 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6740638

Methods for treatment of multiple sclerosis using peptide analogues at position 91 of huma

Neurocrine Biosciences, Inc. · Granted Tue May 25 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6730692

Treatment and prevention of reactive oxygen metabolite-mediated cellular damage

Maxim Pharmaceuticals, Inc. · Granted Tue May 04 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6719969

Treatment of liver disease and injury with CXC chemokines

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Apr 13 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6713056

Combined preparation for the treatment of neoplasic diseases or of infectious diseases

I.D.M. Immuno-Designed Molecules · Granted Tue Mar 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6706686

Inhibition of histone deacetylase as a treatment for cardiac hypertrophy

The Regents of the University of Colorado · Granted Tue Mar 16 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6703050

Methods and compositions for the prevention or treatment of cancer

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Mar 09 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6699842

Dominant negative deletion mutants of C-jun and their use in the prevention and treatment

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 02 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6696407

Huntington's disease treatment comprising administering aldose reductase inhibitors to inc

The Regents of the University of California · Granted Tue Feb 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6693130

Inhibitors of epoxide hydrolases for the treatment of hypertension

The Regents of the University of California · Granted Tue Feb 17 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6692741

Treatment of acute lung injury and fibrosis with antagonists of &bgr;6-specific antibodies

The Regents of the University of California · Granted Tue Feb 17 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6689877

Methods and compositions for the treatment of human immunodeficiency virus infection

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Feb 10 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired